RELATIONSHIP OF CYP2D6 GENETIC POLYMORPHISMS AND THE PHARMACOKINETICS OF TRAMADOL IN CHINESE VOLUNTEERS

被引：0
|
作者：
Li, Qin [1 ]
Zhong, Dafang [2 ]
Lou, Jianshi [1 ]
Wang, Rui [3 ]
机构：
[1] Tianjin Med Univ, Dept Pharmacol, Tianjin 300070, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Metab & Pharmacokinet Res, Shanghai 200031, Peoples R China
[3] Chinese People Liberat Army Gen Hosp, Dept Clin Pharmacol, Beijing 100853, Peoples R China
来源：
DRUG METABOLISM REVIEWS | 2008年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
60
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [41] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [42] Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients
    Chan, Sze Wa
    Chu, Tanya T. W.
    Ho, Chung Shun
    Kong, Alice P. S.
    Tomlinson, Brian
    Zeng, Weiwei
    FRONTIERS IN MEDICINE, 2021, 8
  • [43] Modelling the pharmacokinetics of tramadol: On the difference between CYP2D6 extensive and poor metabolizers
    Di Patti, F.
    Fanelli, D.
    Pedersen, R. S.
    Giuliani, C.
    Torricelli, F.
    JOURNAL OF THEORETICAL BIOLOGY, 2008, 254 (03) : 568 - 574
  • [44] IMPACT OF CYP2D6 GENETIC POLYMORPHISM ON THE PHARMACOKINETICS AND CLINICAL EFFECTS OF FLUOXETINE IN CHINESE PATIENTS
    Yin, O.
    Wing, Y.
    Ching, B.
    Chiu, H.
    Chow, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S83 - S83
  • [45] Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteers
    Otani, M
    Fukuda, T
    Naohara, M
    Maune, H
    Senda, C
    Yamamoto, I
    Azuma, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (5-6) : 395 - 399
  • [46] Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteers
    Masahiro Otani
    Tsuyoshi Fukuda
    Masakazu Naohara
    Hiromi Maune
    Chiaki Senda
    Isamu Yamamoto
    Junichi Azuma
    European Journal of Clinical Pharmacology, 2003, 59 : 395 - 399
  • [47] Influence of CYP2D6*10 on the pharmacokinetics of metoprolol in healthy Korean volunteers
    Jin, S. K.
    Chung, H. J.
    Chung, M. W.
    Kim, J. -I.
    Kang, J. -H.
    Woo, S. W.
    Bang, S.
    Lee, S. H.
    Lee, H. J.
    Roh, J.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (05) : 567 - 573
  • [48] Pharmacokinetics of metoprolol in Chinese of different CYP2D6 genotypes.
    Huang, JD
    Chuang, SK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 226 - 226
  • [49] Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia
    Ismail, R
    Teh, LK
    Amir, J
    Alwi, Z
    Lopez, CG
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (04) : 279 - 284
  • [50] The hypoalgesic effect of tramadol in relation to CYP2D6
    Poulsen, L
    ArendtNielsen, L
    Brosen, K
    Sindrup, SH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) : 636 - 644
12345